Physician

Michael Lewis Mcclintock, M.D.

According to 2025 Medicare claims, Michael Mcclintock, M.D. (NPI: 1871737239) practices ophthalmology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is VISTAR EYE CENTER, INC (NPI: 1457323545; TIN: 540853078) and primary practice location at 24019-3813.

Mcclintock's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 906 traditional Medicare patients, billed 147,339 HCPCS/CPT codes, and received $5,462,074 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 447 prescription claims across 155 beneficiaries totaling $13,336 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 21 records totaling $2,988. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $456,621 to $5,462,074. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,192 and ending at $13,336. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	367	2,112	$456,621
2016	674	7,776	$1,926,206
2017	822	10,155	$2,501,502
2018	1,103	14,881	$3,732,944
2019	1,093	18,458	$4,756,498
2020	1,019	18,027	$5,055,875
2021	983	19,246	$5,432,674
2022	1,021	28,241	$5,512,227
2023	953	91,202	$5,430,754
2024	906	147,339	$5,462,074

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	74	$4,192
2016	108	310	$15,025
2017	116	339	$11,077
2018	168	479	$18,365
2019	202	576	$23,465
2020	179	507	$15,716
2021	200	582	$17,149
2022	189	566	$13,342
2023	177	480	$15,441
2024	155	447	$13,336

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	302	343	$115
67028	Injection of drug into eye	447	2,162	$94
92014	Established patient complete exam of visual system	826	1,610	$83
92134	Imaging of retina	886	3,031	$28
J2777	Injection, faricimab-svoa, 0.1 mg	335	132,780	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	141	4,044	$4,570
Ketorolac Tromethamine	Ketorolac Tromethamine	35	864	$787
Ofloxacin	Ofloxacin	60	1,397	$634
Erythromycin	Erythromycin Base	44	482	$425
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	34	2,791	$356

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$2,988	Glaukos Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Lewis Mcclintock, M.D.?

Tedicare shows public-source Medicare data for Michael Lewis Mcclintock, M.D. (NPI 1871737239), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Lewis Mcclintock, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Lewis Mcclintock, M.D.?

Michael Lewis Mcclintock, M.D. is linked to VISTAR EYE CENTER, INC (billing NPI 1457323545) in the available physician profile data.

Does Michael Lewis Mcclintock, M.D. have Open Payments data?

Michael Lewis Mcclintock, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.